MyClearStep Expands Across Leading Hospitals, Accelerating Adoption of Intelligent Patient Monitoring
Cupertino, CA, November 10, 2025 — MyClearStep, creator of the patented Numberless Scale® and AI-driven monitoring technologies including User Manipulation Trigger (UMT) and Scale Manipulation Trigger (SMT), is redefining patient intake and vitals monitoring across the United States. Trusted by more than 5,000 clinicians, MyClearStep is now expanding into more than 30 new hospitals, strengthening its position as the benchmark for intelligent, patient-centered monitoring.
The MyClearStep platform will be deployed across multi-function inpatient departments and extended into outpatient programs, where it has demonstrated significant value in reducing costs and improving clinical outcomes. For many patients, traditional weigh-ins are a source of anxiety. MyClearStep’s Numberless Scale® removes visible weight readings from the experience, preserving patient dignity while capturing precise, clinically reliable data.
AI-powered analysis further enhances signal quality by identifying subtle behavioral patterns, physical markers, and inconsistencies that standard workflows often miss. Automatically flagged anomalies and validated vitals flow directly into hospital EMRs, providing clinicians with clean, actionable data at scale.
Ensuring Accuracy with UMT and SMT
UMT and SMT are embedded across MyClearStep’s monitoring workflows to ensure every reading is accurate, interpretable, and trustworthy.
- UMT detects behaviors such as water loading, skipped or delayed weigh-ins, and atypical usage patterns, giving clinicians critical context instead of isolated data points.
- SMT protects device integrity by identifying tilted scales, external loads, or improper use that can compromise measurements.
Together, they form a closed-loop quality system that safeguards clinical accuracy, preserves patient experience, and delivers hospital-grade data that providers can rely on.
Cost-Effective for Health Systems and Patients
MyClearStep eases cognitive load that never shows up in accounting and trims intake by about 4 to 6 minutes. At scale, that frees roughly 10 staff hours per 100 patients per day. Operations tighten, labor spend drops, outcomes improve. The device is FDA cleared, HIPAA compliant, and FSA or HSA eligible. It reduces unnecessary visits and testing while keeping care affordable and less taxing for patients.
Proven Impact at Scale
- 7.5M+ vitals captured
- 5,000+ clinics modernized
- 94.7% accuracy in detecting behavioral or device anomalies
- 10+ staff hours saved daily in mid-volume hospital departments
- Clinician satisfaction increased by 62% in pilot programs
“This expansion reflects a fundamental shift in how hospitals approach vitals collection and patient monitoring,” said Nati Lavi, Founder and CEO of MyClearStep. “Adding 30+ major hospitals to our network validates the demand for a smart, reliable, and patient-centered solution. MyClearStep reduces the stress patients feel during intake, delivers precise insights to clinicians, and lowers costs for providers and families. This is how modern healthcare should function.”
For more information, visit: https://www.myclearstep.com/hospitals-clinics-intake-monitoring/
About MyClearStep
Founded in 2020 by CEO Nati Lavi, MyClearStep introduced the first HIPAA-compliant Numberless Scale®, setting a new standard for virtual and in-person care with stress-reducing, clinically rigorous monitoring solutions.
Media Contact
Romana Teague
romana@myclearstep.com
